Published Date: 24 Apr 2023
Germany: One mechanism underlying the rise in has been revealed by a research team at the University of Cologne's CECAD Cluster of Excellence in Aging Research.
Read Full NewsAD109 Yields Numerically Greater OSA Improvements in Postmenopausal Women
CHEST 2026: Day 3 Recap — 6 Headlines to Know
Downar outlines the randomized trial needed to confirm optimal TMS dosing and addresses a safety ceiling on total pulses.
The chief research and medical affairs officer at the National MS Society discussed AI-enabled imaging, biomarkers of progression, women's health across the lifespan, and the Society's Campaign to End MS.
One-year data from the phase 3 AQUARELLE study found that divozilimab, an anti-CD20 antibody, reduced relapse risk in patients with neuromyelitis optica spectrum disorder.
Early phase 1 data in 3 patients suggest CTA313, an allogeneic CD19/BCMA CAR-T, may stabilize disability with a manageable safety profile in progressive MS.
Fast Track status covers AV-1959R, an investigational amyloid-beta vaccine, for preventing Alzheimer disease in cognitively unimpaired adults with amyloid pathology.
1.
First-Line T-DXd Boosts PFS in HER2-Mutant NSCLC
2.
Children with rare gliomas have new hope thanks to clinical trial results.
3.
GLP-1 receptor agonists, cancer risk and questionable significance
4.
Global inequalities found in cancer research funding
5.
According to a study, male testicular cancer risk is linked to neurodevelopmental disorders.
1.
Innovative Advances in Oncology for Specialists
2.
Blastic Plasmacytoid Dendritic Cell Neoplasm and the Dawn of AI-powered Diagnostics
3.
Extracellular Protein Signatures of Megakaryocyte Activation
4.
Unlocking a New Era in Bladder Cancer Treatment: A Review of the TAR-200 Intravesical Drug Delivery System
5.
Exploring the Potential of Bendamustine in Cancer Treatment
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
3.
Understanding the Importance of Follow-Up After Cancer Treatment
4.
Understanding the Role of Screening in Cancer Prevention
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation